Investor Relations

Stock price graph

PTC Therapeutics, Inc. is committed to serving the interests of our shareholders. This part of our website includes corporate governance documents, press releases, financial information and other documents to help shareholders better understand who we are and what we do.

View all »   RSSRecent Releases

Dec 19, 2014
Translarna Granted Orphan Drug Designation in the U.S. and Europe for the Treatment of Mucopolysaccharidosis I

Dec 17, 2014
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4)